GHO Capital announces increased investment in Validant, alongside management, to accelerate global build-out

Posted: 10 May 2022
  • Validant has grown into the global leader in quality, compliance & regulatory healthcare consulting
  • Fresh capital to fuel continued geographic and product / service line expansion
  • Management and GHO are partnering with Goldman Sachs Asset Management and LACERA to support the next stage of the company’s growth

    London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, announces an increased investment in its portfolio company Validant, the leading international provider of quality, compliance and regulatory affairs consulting to Biotech, Pharma and MedTech companies.

    In just three years of partnership with GHO, Validant has more than tripled in size, significantly broadening its footprint throughout the US, Asia and Europe through rapid organic growth and strategically accretive M&A. To support this growth, the business substantially enhanced its management team and heavily invested in infrastructure to allow the business to operate on a global scale.

    Validant’s 2019 to 2021 combination with DataRevive, IDEC, Oriel Stat-A-Matrix, Greenleaf Health and Clinical Outcomes Solutions has transformed the group into a global, full-service life science consulting firm focused on managing and resolving complex regulatory issues.

    The increased investment from GHO, alongside Validant’s management team, is supplemented with a new consortium of investors led by funds managed by Goldman Sachs Asset Management and the Los Angeles County Employees Retirement Association (“LACERA”).

    With fresh capital and an extended time frame to drive additional value accretion, Validant is well positioned for the next stage of its expansion as it further cements its position as the global leader in quality, compliance and regulatory affairs healthcare consulting. This will be achieved organically with the roll-out of existing services, expansion into geographic and service adjacencies as well as through transformative strategic add-on acquisitions.

    Founded in 2005, Validant is an established global leader in the healthcare consulting sector with 265 employees operating across three continents and serving more than 1,000 customers. The Group is renowned for its industry-leading technical expertise, customer-centric approach and focus on patient safety as it expertly helps its clients navigate across multiple markets in an increasingly challenging and complex regulatory environment.

    The Partners at GHO Capital, said, “We are thrilled to continue our partnership with Validant, working closely with Patrick and the management team. We are proud of the business that we have built, driven by its technical focus and patient-first orientation. Recognising the outsized structural long-term growth opportunities that lie within the sector, we are confident that GHO’s continuity in strategic and operational support will be instrumental in facilitating Validant’s next chapter of growth, supporting a shared ambition to build a full-service, international leader in regulatory affairs.”

    Patrick Ronan, CEO of Validant, said: “As we move into the next chapter of our evolution, we are delighted to have GHO’s continued backing. GHO will provide the additional resources and expertise that will empower us to achieve considerable global expansion, investing further in our organizational infrastructure to meet a growing base of global customers. The continued support allows us to build on our position as a market leader, taking advantage of opportunities for both organic and strategic growth.”

    Rede Partners acted as financial advisor to GHO, Ropes & Gray LLP and Kirkland & Ellis International LLP acted as legal advisors, L.E.K. Consulting as commercial advisor, Deloitte LLP as financial and tax advisor and Ernst & Young LLP as ESG advisor.

About GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. We apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalisation to build market leading businesses of strategic global value. Our proven investment track record reflects the unrivalled depth of our industry expertise and network. We partner with strong management teams to generate long-term sustainable value, improving the efficiency of healthcare delivery to enable better, faster, more accessible healthcare. For further information, please visit

About Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. With deep experience working within and alongside the FDA and other regulatory agencies, we understand how to navigate the complexities facing today’s healthcare industry. For further information, please visit